Chinese pathology equipment manufacturers are accelerating global expansion, with Chensi Biotechnology (Kunming) Co., Ltd. tapping markets across Southeast Asia, Europe and the United States.
Chensi Bio plans overseas business to account for nearly 50% of its first-year revenue with annual growth exceeding 50%. The brand wins global clients via balanced reliable performance and competitive pricing without excessive brand premium.
Three core strengths support its overseas layout. First, comprehensive product portfolio covering all steps of histology experiments for one-stop purchasing. Second, flexible customization services including OEM, ODM, private label packaging, specification adjustment and exclusive product sets for distributors. Third, full international service: English datasheets, export packaging, global logistics coordination and long-term stable supply guarantees.
“Overseas labs and distributors prioritize stable supply and professional technical guidance,” said Chensi Bio’s international sales director. The team provides tailored product selection suggestions and accepts small trial orders for market testing.
Industry observers note surging demand for cost-effective pathology instruments in emerging Southeast Asian markets, and Chinese manufacturers hold huge export potential. Chensi Bio’s overseas layout helps raise the global market share of China-made pathological lab products.